Nanjing Kaiyuan Growth Capital Investments has 1 portfolio company on record at Recent Funding. Its most recent investment on record is Personal Genome Diagnostics's $21M Series A round in October 2015, alongside Windham Venture Partners and NEA. That company is in Health and bio.

What Nanjing Kaiyuan Growth Capital Investments invests in

• Health and bio · 1 · 100%
• Data and analytics · 1 · 100%

How Nanjing Kaiyuan Growth Capital Investments invests

Share is of the 1 round on Recent Funding that name Nanjing Kaiyuan Growth Capital Investments. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Nanjing Kaiyuan Growth Capital Investments portfolio companies

• PPersonal Genome Diagnostics$21MSeries A · Oct 2015

Most frequent co-investors

• NNEA1 shared round · last Oct 1, 2015
• WWindham Venture Partners1 shared round · last Oct 1, 2015

Similar investors

• 221501 company · 1 deal in 12 mo
• CCove Hill Partners1 company · 1 deal in 12 mo
• DDSW Ventures1 company · 1 deal in 12 mo
• NNorth Bridge Venture Partners & Growth Equity1 company
• CCastrum Capital2 companies · 2 deals in 12 mo
• SSelah Ventures2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Nanjing Kaiyuan Growth Capital Investments, which is a subset of its real portfolio. API: /api/v1/investors/nanjing-kaiyuan-growth-capital-investments (get a free API key). More: the most active VC firms and new venture capital funds.